ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DFFN Diffusion Pharmaceuticals Inc

4.40
0.00 (0.00%)
Jun 13 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 4.48
Ask Price 4.50
News (9)
Day High

Low
4.14

52 Week Range

High
7.785

Day Low
Company Name Stock Ticker Symbol Market Type
Diffusion Pharmaceuticals Inc DFFN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 4.40 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.40 4.40
Trades Volume Avg Volume 52 Week Range
0 0 - 4.14 - 7.785
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 4.40 USD

Diffusion Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
24.97M 5.68M - 7.15M -2.17M -0.38 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Diffusion Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DFFN Message Board. Create One! See More Posts on DFFN Message Board See More Message Board Posts

Historical DFFN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year5.2057.7854.145.7418,963-0.805-15.47%
3 Years1.170314.0250.2490.9289566524,2183.23275.97%
5 Years4.8014.0250.2491.291,881,855-0.40-8.33%

Diffusion Pharmaceuticals Description

Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer.

Your Recent History

Delayed Upgrade Clock